Breast Cancer Tamoxifen Dose Escalation in Patients With Diminished CYP 2 D 6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity
暂无分享，去创建一个
J. Ibrahim | L. Carey | H. McLeod | J. Peppercorn | D. Flockhart | C. Walko | G. Schwartz | Z. Desta | S. Anderson | M. Graham | K. Weck | David R. Jones | O. Olajide | D. Hertz | S. Moore | R. Raab | D. Carrizosa | S. Corso | W. Irvin | J. Evans